Financing channel feed – Endpoints News

Financing channel feed

Exclusive: Gates Foundation backs startup using optogenetics to manufacture biologics

9 months ago

Why a new health tech venture firm is investing only in founders with a healthcare background

9 months ago

Halda adds $126M to test oral drugs for prostate, breast cancer

9 months ago

Exclusive: MIT spinout launches with focus on improving DNA payloads for gene insertion

9 months ago

IDRx raises $120M for targeted GIST drug following leadership change

9 months ago

TPG reveals $580M life sciences fund, which has already backed multiple biotechs

9 months ago

Eisai picks SEED Therapeutics for molecular glue deal worth as much as $1.5B

9 months ago

Arie Belldegrun and team unveil $600M life sciences credit firm amid struggling biotech market

9 months ago

Exclusive: TCG, DCVC and Lux back new autoimmune biotech from Kallyope co-founder

9 months ago

Japanese government grants Shinobi $59M for cell therapy development

9 months ago

A new Apple Tree Partners biotech launches with $55M to make ‘pan-variant’ antivirals

9 months ago

MBX Biosciences rakes in $63.5M for peptide therapies

9 months ago

Exclusive: Devoted Health raises $112M, plots insurance markets expansion

9 months ago

Apogee and Spyre founder launches another autoimmune biotech, and it's got $80M to start

9 months ago

Exclusive: Ultragenyx secures first funds for Alzheimer's gene therapy spinout

9 months ago

With $144M Series B, Outpace Bio beats funding goal for solid tumor cell therapies

9 months ago

VC firm venBio secures $528M for ‘extremely selective’ fifth fund after recent IPOs, M&A exits

9 months ago

Rare disease biotech raises $47M Series C, plans for Phase 2 trial

9 months ago

As Amgen pursues GIP antagonism, a Novo Holdings-backed biotech does the same, boosting its Series A

9 months ago

RNA editing startup AIRNA raises $60M for clinical trial in rare liver disease

9 months ago

Exclusive: Startup aims to tackle ‘undruggable’ neuro targets with tech from Kevan Shokat's UCSF lab

9 months ago

In a tough market, private biotechs pursue IPOs and buyouts at the same time

9 months ago

Chinese biotech developing semaglutide biosimilar files for Hong Kong IPO

9 months ago

With new mission in psychiatry, Autobahn raises $100M to help back Phase 2 work

9 months ago

First page Previous page 9 10 111213 14 15 Next page Last page